G. Hennig

发表

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods.

Uwe Rogel, Peter Fritz, K. Schaefer, 2009, Clinical chemistry.

Applicability of a System for Fully Automated Nucleic Acid Extraction From Formalin-fixed Paraffin-embedded Sections for Routine KRAS Mutation Testing

W. Weichert, C. Denkert, M. Dietel, 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

R. Greil, H. Brauch, M. Gnant, 2011, Clinical Cancer Research.

Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression (*)

W. Birchmeier, J. Behrens, G. Hennig, 1996, The Journal of Biological Chemistry.

Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer

C. Denkert, M. Dietel, H. Bojar, 2014, Virchows Archiv.

Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue—A New Option for Predictive Biomarker Assessment in Breast Cancer

Carsten Denkert, Wilko Weichert, Manfred Dietel, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

CDK10 is not a target for aberrant DNA methylation in breast cancer.

M. Gehrmann, M. Filipits, S. Zöchbauer-Müller, 2009, Anticancer research.

Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerization.

R. Müller, G. Hennig, M. Schuermann, 1991, Nucleic acids research.

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

N. Pavlidis, H. Gogas, R. Wirtz, 2009, Breast Cancer Research and Treatment.

Conventional Clinical Risk Factors HER 2-Negative Breast Cancer Adds Independent Information to A New Molecular Predictor of Distant Recurrence in ER-Positive

R. Greil, H. Brauch, M. Gnant, 2011 .

Imaging , Diagnosis , Prognosis A New Molecular Predictor of Distant Recurrence in ER-Positive , HER 2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

R. Greil, H. Brauch, M. Gnant, 2011 .

Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.

W. Birchmeier, S. Frisch, M. Truss, 1995, Oncogene.

Quantitative determination of predictive cancer biomarkers in formalin-fixed, paraffin-embedded tissue using a new, fully automated method for RNA isolation.

G. Kristiansen, K. Winzer, C. Denkert, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection

T. Sørlie, F. B. Sørensen, S. Myhre, 2013, Virchows Archiv.

Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.

Hiltrud Brauch, Michel Eichelbaum, H. Brauch, 2010, Clinical chemistry.

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival

M. Dimopoulos, N. Pavlidis, H. Gogas, 2006, Breast Cancer Research and Treatment.